Are You Currently Being Treated for a Relapsing Remitting Form of Multiple Sclerosis?
A voluntary research study is currently being conducted to evaluate different medications that treat relapsing remitting forms of multiple sclerosis (MS).
You may qualify to participate in this voluntary research study if you:
are between the ages of 18 and 65
have been diagnosed with a relapsing remitting form of MS
are naïve to treatment; or have 5 years or less of total lifetime exposure to one class of Disease Modifying Therapy (DMT)
Qualified participants will receive study-related exams and study medication at no cost.